CNS

CNS held a demonstration presenting a precision spray mist system it calls a way to cool AI servers, billed as a response to what it describes as 'explosive fever' in server hardware. The company positioned the technology for data centres running intensive AI workloads, where heat management is a growing bottleneck. Details on deployment partners or performance figures were not provided.

Autobahn Therapeutics is a regenerative medicine spinout focused on the central nervous system, backed by Oregon Health & Science University. The company is developing therapies aimed at repairing damaged neural tissue, building on research originating at OHSU. It is listed among university-affiliated biotech ventures in deal databases tracking spinouts.